Breast cancer is the most common neoplasm in European and North American women, with long-term survival anticipated in most women who are diagnosed with localized disease. Among the quality of life and rehabilitation outcomes after breast cancer, sexual functioning is an important consideration [1] . Breast conserving surgery was popularized initially as a way of improving quality of life (including sexual functioning) after breast cancer; however, a series of studies have failed to demonstrate major differences in quality of life between patients receiving complete mastectomy compared with partial mastectomy [2] [3] [4] [5] , suggesting that the impact of the cancer diagnosis itself is probably more critical in affecting quality-of-life outcomes than the specific type of surgery. However, research has documented that the choice of surgical treatment plays an important role in adaptation and quality of life after breast cancer [6] . In addition to acknowledging the importance of a woman's own preferences regarding her body, having the patient participate in the decision regarding surgical treatment also provides an opportunity for her to obtain more accurate information about her diagnosis and prognosis.
Although body image is significantly better in women receiving breast conservation surgery, the type of surgery does not appear to impact on sexual functioning and its recovery after a breast cancer diagnosis [3, 4] . In a prospective longitudinal study, Ganz et al. saw no change in sexual functioning during the year after breast cancer diagnosis (independent of type of surgery) and observed significant worsening in sexual functioning over the subsequent three years of follow-up [4, 7] . In contrast, other aspects of quality of life recovered during the year following diagnosis, and remained fairly stable thereafter during the same three-year follow-up interval [7] . This finding suggested a possible long-term effect of the breast cancer diagnosis and treatment on sexual functioning that merited further inquiry [7] . Increasingly, other investigators have identified sexual functioning as an important concern for breast cancer survivors [1, 8] .
In this issue of Annals of Oncology, Barni and Mondin [8] report the results of a cross-sectional survey that assessed sexual functioning in a small and selected sample of 50 Italian breast cancer survivors recruited from their oncology practice. The sample was selected based on being at least 12 months since surgery, currently sexually active, between 20 and 65 years, and disease-free. Apparently, all of the eligible patients approached by the investigators were willing to complete an anonymous questionnaire that was returned by mail. On average, the breast cancer survivors in this sample were 2.9 years from diagnosis, with 42% having received breast conserving surgery. The vast majority of patients had received chemotherapy (88%), with very few on hormone therapy (4%). The average age of the respondents was 48 years, and almost all were married (96%>). As can be seen from these medical and demographic characteristics, the survey respondents were highly selected and not representative of the general population of breast cancer survivors. While this severely limits the generalizability and strength of the conclusions that can be made from this study, the authors are to be congratulated on opening the door to this type of research.
In their study [8] , Barni and Mondin found that sexual dysfunction was frequent in breast cancer survivors and that lack of sexual desire (48%) was the most common problem, followed by lack of orgasm (44%>), and problems with lubrication (42%). Of note, 36% of the sample reported that their sexual problems preceded the cancer diagnosis; however, another 38% of the sample attributed their problems to breast cancer treatment, having never experienced the problem before that time. Given the small and selected nature of the sample, the cross-sectional rather than longitudinal design, and the absence of normative reference data in an agematched Italian sample, it is difficult to conclude that the sexual dysfunctions reported in this study are related to the breast cancer diagnosis and treatment. Further, the small sample size limited statistical evaluation to determine if age, type of treatment, or other factors predicted these dysfunctions. Nevertheless, this report documents that breast cancer survivors are experiencing high rates of sexual dysfunction which clinicians may not be aware of. In particular, problems with vaginal dryness and dyspareunia can be managed with specific treatments [9] , and health care professionals should inquire about these problems and suggest symptomatic management to their patients.
Other descriptive findings emerging from this study [8] include the report of positive aspects of breast cancer for the partner relationship, as well as the finding of a stable or improved quality of sexual activity for almost half of the sample. These survivors identified their worries about their own health as the most important factor affecting their partner relationship and their sexual habits. In addition, psychological, emotional, and sexual problems were most often discussed with partners (62%) rather than with health care professionals (15%).
These observations likely reflect the discomfort of health care professionals in addressing issues related to sexuality and intimacy, which is probably perceived by the patient, thereby inhibiting discussion of these personal matters. As more information is obtained about the type and nature of sexual problems in breast cancer survivors, health care professionals should be able to take a more pro-active role in counseling patients about this aspect of their recovery. The report in this issue of Annals provides a first step in that direction.
How does the report in this issue [8] and the work of our research group [10] help to understand sexual functioning after breast cancer? In an ongoing research study, we surveyed over 800 disease-free breast cancer survivors in the US, who were one to five years after the diagnosis of breast cancer (on average about three years after diagnosis). We used standardized measures of the partner relationship, sexual functioning, and symptoms, that had reference data in samples of healthy US women. Our survey also found high rates of some of the same sexual problems noted by Barni and Mondin [8] , e.g., vaginal dryness. However, many of these problems are reported in healthy women, albeit at a lower rate of occurrence [11] . An important covariate in our analyses was the prior use of chemotherapy, which proved to be a predictor of poorer sexual functioning at all ages [10] . There was a particularly significant impact in younger women who were made menopausal prematurely as a result of chemotherapy (unpublished data). Vaginal dryness and dyspareunia are two symptoms that were reported more frequently in our sample of breast cancer survivors than in healthy controls; however, in spite of these findings, we found that sexual functioning was similar to age-matched healthy controls (unpublished data). How can we explain this paradoxical observation? Sexual activity and functioning are the result of a complex set of physical and psychological factors. Although some physical symptoms have the potential to detract from sexual activity, other independent physical and psychological factors may in fact predominate as determinants of sexual functioning, such as age-related changes in desire and arousal. For this reason, breast cancer survivors may report sexual functioning that is similar to healthy women, in spite of some apparent increase in particular symptoms. Specific research is necessary to determine if treatment of symptoms such as vaginal dryness will improve sexual functioning in breast cancer survivors.
An emerging body of research on women's health suggests that sexual functioning declines with age in healthy women [11, 12] , and that these changes are temporally related to the menopause. Vaginal dryness and dyspareunia increase after the menopause in healthy women, and these symptoms are responsive to estrogen replacement therapy (either systemic or topical). However, there is little evidence that estrogen replacement therapy positively affects sexual desire or arousal in the postmenopausal woman. In women with breast cancer, chemotherapy has been reported to affect vaginal lubrication acutely, and the induction of premature menopause in younger women contributes to ongoing problems with vaginal lubrication after chemotherapy is completed. The longer-term effects of chemotherapy on the vaginal mucosa in menstruating and postmenopausal women warrant further investigation. Vaginal dryness and its associated dyspareunia can establish a vicious cycle in which sexual activity is painful rather than pleasurable, resulting in avoidance of sexual activity. Treatment of vaginal dryness with vaginal moisturizers or topical estrogen may provide substantial relief of this symptom for women with breast cancer [9] . The current medical prohibition of estrogen replacement therapy in breast cancer survivors is being called into question [13, 14] . The safety of postmenopausal estrogens in breast cancer survivors for symptom relief, as well as for other long-term health benefits, is likely to receive systematic evaluation in the near future [14] .
To understand health-related quality of life and sexual functioning in breast cancer survivors, we must frame the evaluation in the context of healthy women, and examine how the breast cancer diagnosis adds to other known influences on the aging woman's health and functioning. As breast cancer is primarily a disease of aging women, this is particularly salient. Figure 1 proposes a conceptual framework for use in future studies. All breast cancer survivors experience agerelated changes in well-being and functioning that occur as a result of declining physical abilities, from minor illnesses or some chronic conditions that increase with aging. Age-related changes in quality of life and sexual functioning occur independently of breast cancer. Extrinsic factors such as access to health care, socioeconomic status, employment status, presence or absence of a partner, the quality of the partnered relationship, etc., all affect the assessment of quality of life. Intersecting with this pre-existing state are factors related to a woman's reproductive health status and where she is in her life cycle: Has she completed childbearing? Does she already have signs of ovarian functional decline (perimenopausal transition)? Has she
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Quality of Life After Breast Cancer stopped menstruating recently? Does she have symptoms of estrogen deficiency? Was she on hormone replacement therapy at the time of her breast cancer diagnosis? The menopause frequently intersects with breast cancer, making this aspect of reproductive functioning particularly important for its impact on quality of life and sexual functioning after breast cancer. It is also critical to remember that the physical and psychological impact of the menopause varies across nationalities and ethnic/cultural groups [15] . The last element in this conceptual framework is breast cancer, which initiates a series of medical interventions and psychological threats that forever affect the woman with this disease. While breast cancer is a very serious condition, the literature provides substantial evidence of the positive, long-term adaptation of breast cancer survivors with respect to the major dimensions of quality of life (physical, emotional and social well-being) [7] . Although some breast cancer survivors will attribute their symptoms and dysfunction to the disease and its treatment, it is often difficult to distinguish these effects from other age-related and reproductive health factors that are independent of the cancer. Nevertheless, there may be subgroups of breast cancer survivors whose quality of life is more seriously affected by the cancer treatment, e.g., younger women [16] . Examining the impact of a breast cancer diagnosis from the larger perspective of women's health across the life trajectory can contribute new insight and understanding. Cancer survivorship research requires the careful use of comparative data from healthy, age-matched populations, and the results of this research must be interpreted with caution unless normative data are available. This conceptual framework is presented as a suggestion to researchers who are designing new studies to examine quality of life and sexual functioning in breast cancer survivors. However, it is also a useful tool for clinicians who will be caring for a growing number of breast cancer survivors in the future.
